24/7 Customer Support

Japan Epigenetics Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2027

Japan Epigenetics Market- (By Product Type- Reagents, Kits, Instruments, Software Tools, Enzymes, Proteins & Peptides, Antibodies and Services; By Technology- DNA Methylation, Histone Methylation, Histone Acetylation, Bromodomains, Non-coding RNA and Other; By Application- Oncology and Non-oncology; By End Users- Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Research and consulting firms; and By Country) - Industry Dynamics, Market Size and Opportunity Forecast, 2027

  • Published Date: May-2022  |   Format: pdfpowerpointexcel  |  Report ID: AA0522219  | Delivery: 2 to 4 Hours
Japan Epigenetics Market

View Full Infographic


Epigenetics is a branch of genetics concerned with the study of cellular and physiological trait variations caused by environmental or ecological factors that turn genes on and off and influence cellular ability to read genes without being affected by genotype changes.

Biology and genetic expressions of most organisms are affected by epigenetics, which makes it one of the most crucial fields of developmental genetics and molecular biology.

Epigenetic changes are essential for development since they are dynamic and change in response to external stimuli.

The expected growth rate of the Japan epigenetics market is 12.8%, with an estimated value of US$ 48.6 Million by 2027. 

Factors such as growing R&D expenditure in the pharmaceutical & biopharmaceutical industry and growing adoption of epigenetics for cancer treatment will boost the Japan epigenetics market during the forecast period. 

The novel COVID-19 has seen a significant impact on the epigenetics market. Japan epigenetics market is witnessed a slight decline of approx. 3.2% in 2020, in the recent outbreak of the COVID-19 pandemic.

Based on technology, the epigenetics market is segmented into DNA methylation, histone methylation, histone acetylation, bromodomains, non-coding RNA and others.

High cost of epigenetics instruments and dearth of skilled workforce is a restraining factor which inhibits the growth of the epigenetics market during the forecast period. 

The oncology segment is expected to project the highest CAGR over the forecast period in the Japan epigenetics market.

Product type, technology, application and end-users are the different segments to invest in over the assessment period in the Japan epigenetics market.

Innovative growth strategies are likely to provides a lucrative growth trend in the Japan epigenetics market. 

The key players operating in the market include Epigenereon, National Institute of Genetics, Rhelixa Inc., RIKEN, Illumina, Inc., Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Limited and Abcam PLC among others.